Related Experiment Video
Updated: Aug 18, 2026
Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Genomic deletions in cell lines derived from primitive neuroectodermal tumors of the central nervous system
Peter B Dallas1, Philippa A Terry, Ursula R Kees
1Division of Children's Leukemia and Cancer Research, Telethon Institute for Child Health Research and Center for Child Health Research, The University of Western Australia, P. O. Box 855, West Perth, WA 6872, Australia. peterd@ichr.uwa.edu.au
Abstract:
Extensive genomic deletions affecting a variety of chromosomes are a common finding in primitive neuroectodermal tumors of the central nervous system (CNS-PNETs), implicating the loss of multiple tumor suppressor genes in the pathogenesis of these tumors. We have used representational difference analysis, microsatellite mapping, and quantitative polymerase chain reaction to identify and verify the presence of genomic deletions on a number of chromosomes in CNS-PNET cell lines. This systematic approach has confirmed the importance of deletions at 10q, 16q, and 17p in PNET pathology and has revealed other regions of deletion not commonly described (e.g., Xq, 1p, 7p, and 13q). These data highlight the prevalence of hemizygous loss in CNS-PNET cells, suggesting that haploinsufficiency affecting multiple tumor suppressor genes may play a fundamental role in CNS-PNET pathogenesis. The identification of specific genes and signaling pathways that are compromised in CNS-PNET cells is crucial for development of more efficacious and less invasive treatments, as are urgently needed.
Insights
Genomic deletions are common in central nervous system primitive neuroectodermal tumors (CNS-PNETs). These deletions suggest that the loss of tumor suppressor genes contributes to CNS-PNET development.
Area of Science:
- Genomics
- Oncology
- Neuroscience
Background:
- Primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) frequently exhibit extensive genomic deletions.
- These deletions suggest the involvement of multiple tumor suppressor genes in CNS-PNET pathogenesis.
Purpose of the Study:
- To identify and verify genomic deletions in CNS-PNET cell lines.
- To understand the role of genomic instability in CNS-PNET development.
Main Methods:
- Representational difference analysis
- Microsatellite mapping
- Quantitative polymerase chain reaction (qPCR)
Main Results:
- Confirmed deletions at 10q, 16q, and 17p in CNS-PNETs.
- Identified novel deletion regions including Xq, 1p, 7p, and 13q.
- Demonstrated a high prevalence of hemizygous loss, indicating haploinsufficiency of tumor suppressor genes.
Conclusions:
- Haploinsufficiency of multiple tumor suppressor genes likely plays a critical role in CNS-PNET pathogenesis.
- Identifying compromised genes and pathways is essential for developing targeted CNS-PNET therapies.
